Business Type Exporter, Manufacturer, Supplier Payment Mode Telegraphic Transfer (T/T) Explore Related Categories More Products From This Seller Seller Details Fuqiang Road, Futian District, Shenzhen, Guangdong, 000000, China Compare With Similar Products Price Or Price Range 45.0 USD ($) (Approx.) 250 INR (Approx.) Minimum Order Quantity 500 Box/Boxes 150 Strip/Strips 1 Bottle/Bottles Efficacy Other Other, Promotes healthy weight gain and muscle mass increase Storage Instructions store the products at 2-8 in refrigerator Store in a cool, dry place below 25AdegC away from direct sunlight and moisture Store in a cool, dry place away from direct sunlight Packaging Size 10 vials ( bottle ) / box ( kit ) 200 gm, 400 gm, 500 gm, 1 kg Payment Terms Others, Paypal, Telegraphic Transfer (T/T), Western Union Cash Against Delivery (CAD), Cheque Supply Ability 5000 Per Month 350 Per Week 100 Per Month Sample Policy Contact us for information regarding our sample policy Contact us for information regarding our sample policy Packaging Details 10 vials ( bottle ) / box ( kit ) As an Industrial standard Medicine Type Allopathic tablet / Nutraceutical nerve supplement Ayurvedic Health Supplement Life Span Stable during labeled shelf-life under recommended storage conditions Up to the Best Before date when stored properly Chemical Composition Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, Folic Acid, Levocarnitine and multivitamin blend (composition may vary by manufacturer) Natural herbal blend with essential nutrients People Also Viewed
GLP-1 Receptor Agonists - Podcast Version GLP-1 (glucagon-like peptide-1) receptor agonists are injectable medicines used for the treatment of type 2 diabetes and, more recently, for weight management
Methylglyoxal, the Dark Side of Glycolysis. Frontiers in Neuroscience 9: 23
Organizations are balancing the ongoing demand from employees for GLP-1 coverage for weight loss by continuing to explore feasibility through cost-control mechanisms. Cost-Control Mechanisms Of those covering GLP-1 drugs, employers are using eligibility requirements (45%) and an annual maximum (32%) as cost-control mechanisms
